Qingyan Huayang Capital

The firm has not publicly disclosed its founding team or investment committee. Names of principals are absent from corporate registries and commercial databases, which is typical for early-stage Chinese PE shops that operate without institutional limited partners and avoid media profiling.

The firm describes its strategy as early-stage, covering seed and start-up phases. In the Chinese venture market, that generally means initial tickets in the RMB 1 million to 10 million range, often structured as equity or convertible notes into pre-revenue companies. No specific fund size or per-deal allocation has been disclosed.

No public investment thesis has been published. Given Tianjin's municipal focus on advanced manufacturing, new materials, fintech, and biotech, the firm likely evaluates deals across these priority verticals, but without a portfolio disclosure this remains inference based on regional government guidance.

While the name "Qingyan" is commonly associated with Tsinghua-linked spinouts and funds in China, no formal university affiliation has been confirmed through public records. Any connection is currently unverified and may be informal — an alumni relationship rather than a direct balance-sheet or licensing tie.

Without a disclosed track record, deal origination likely runs through university incubator networks, local government-guided fund platforms, and alumni investor circles — the dominant sourcing channels for early-stage managers based in second-tier Chinese tech hubs like Tianjin rather than Beijing or Shenzhen.